Skin cancer jab

Skin cancer jab: introduction

Skin cancer is one of the most common types of cancer worldwide. According to the World Health Organization (WHO), more than 2 million people are diagnosed with skin cancer every year. Fortunately, there is a new hope for those at high risk of developing skin cancer - a skin cancer jab. This jab has been developed to prevent one of the most deadly types of skin cancer, melanoma.

How does the skin cancer jab work?

The skin cancer jab, also known as the melanoma vaccine, works by stimulating the immune system to attack cancer cells. The vaccine contains a small piece of protein that is found in most melanoma cells. This protein is harmless on its own, but when given to the body, it triggers an immune response. The immune system then recognizes the protein as foreign and begins to attack it. This immune response helps prevent the development of melanoma by destroying any cancerous cells that may form in the body. This new method of fighting skin cancer is promising and has the potential to save millions of lives in the future.